New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2014
09:26 EDTPGNX, CRUS, MDVN, T, BKU, EMC, YHOO, DOW, FSL, ONVO, EA, BAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 6%... Electronic Arts (EA), up 2.5%... Freescale (FSL), up 13%. ALSO HIGHER: Medivation (MDVN), up 13% after Phase 3 PREVAIL trial with Astellas Pharma (ALPMY) of enzalutamide showed significant benefits in OS... Organovo (ONVO), up 16% after announcing first delivery of 3D liver tissue. DOWN AFTER EARNINGS: Boeing (BA), down 4%... Yahoo (YHOO), down 6%... AT&T (T), down 3.5%... Tupperware Brands (TUP), down 7%... Hess (HES), down 1.4%... EMC (EMC), down 1%... ALSO LOWER: Cirrus Logic (CRUS), down 7.5% after reporting Q3 earnings that beat estimates but giving a Q4 revenue outlook that widely missed expectations... Progenics Pharmaceuticals (PGNX), down 18.5% after abstract for drug trial posted... BankUnited (BKU), down 1.4% after filing to sell 8M common shares for holders.
News For BA;DOW;T;EA;YHOO;MDVN;ONVO;EMC;CRUS;FSL;BKU;PGNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 24, 2015
16:00 EDTTOptions Update; August 24, 2015
Subscribe for More Information
07:02 EDTMDVNMedivation to acquire worldwide rights to Talazoparib from BioMarin
Medivation (MDVN) and BioMarin Pharmaceutical (BMRN) have entered into an asset purchase agreement under which Medivation will acquire all worldwide rights to talazoparib, a highly-potent, orally-available poly ADP ribose polymerase inhibitor currently in a Phase 3 study for the treatment of patients with deleterious germline BRCA 1 or BRCA 2 mutations and locally advanced and/or metastatic breast cancer. Under the agreement, Medivation will be responsible for all research, development, regulatory and commercialization activities for all indications on a global basis. Under the terms of the agreement, Medivation will pay BioMarin $410 million upfront, up to an additional $160 million upon the achievement of regulatory and sales-based milestones and mid-single digit royalties for talazoparib. At the closing of the transaction, Medivation will assume all financial obligations associated with the development and commercialization of talazoparib. The closing of the transaction is conditioned on the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction is anticipated to close in 2015.
August 23, 2015
19:13 EDTTBT executive says Verizon, AT&T abusing landline duopoly, FT reports
In a Financial Times interview published Sunday, BT Group's (BT) Americas president Bas Burger said Verizon (VZ) and AT&T (T) are abusing their control over telephone and broadband lines to charge inappropriate access fees to companies like BT. "For a western world country it is the worst I've seen... There is not sufficient regulation to create competition: almost all access is being provided by two companies and they have divided the country among themselves," remarked Burger, adding that the two companies are also not required to fix network problems within any specific timeframe. Reference Link
18:06 EDTBABoeing loses $85M contract over Ex-Im Bank uncertainty, WSJ says
Subscribe for More Information
14:41 EDTBABoeing delivers next-generation 737-800 to Nok Air
Subscribe for More Information
August 21, 2015
17:46 EDTBABoeing on schedule to meet 737 MAX production targets, Reuters says
Subscribe for More Information
16:01 EDTEMCOptions Update; August 21, 2015
Subscribe for More Information
06:07 EDTBABoeing, GKN grapple to produce critical component for 737 Max, WSJ reports
Boeing (BA) and GKN PLC (GKNLY), a key supplier, are grappling to produce a critical component for the updated version of its 737 jet, The Wall Street Journal reports. Boeing has plans to quickly boost production of the 737 Max, but difficulty consistently manufacturing part of the engine thrust reverser, industry executives and engineers are concerned that a shortage of the part could derail Boeing's ambitious plans, the report says. Reference Link
August 20, 2015
14:39 EDTEMCEarnings Watch: Hewlett-Packard reports ahead of company split
Subscribe for More Information
12:05 EDTBABoeing reports eight new orders in weekly update
Subscribe for More Information
08:02 EDTTFCC to hold a conference and workshop
2015 Supplier Diversity Conference & Workshop is being held at FCC Washington, D.C. offices on August 20 at 9:30 am. Webcast Link
05:55 EDTCRUSCirrus Logic pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Ruben Roy recommends using the recent pullback in shares of Cirrus Logic as a buying opportunity. The stock is down 23% from the post earnings highs in late July, Roy tells investors in a research note. After hosting investor meetings with Cirrus Logic CEO Jason Rhode, Roy believes increasing dollar content in upcoming handsets and revenue diversification will remain key themes for the company over the next 18 months. He views Cirrus as the "strongest beneficiary" from expanding voice activation applications in portable and mobile devices. Roy reiterates an Overweight rating on the stock with a $44 price target.
05:47 EDTBABoeing says Qantas intends to purchase eight 787-9 Dreamliners
Subscribe for More Information
August 19, 2015
16:34 EDTBAAir Lease delivers one Boeing 737-800 to American Airlines
Subscribe for More Information
10:20 EDTTBig telecom firms put M&A on hold, CTFN reports
Subscribe for More Information
09:33 EDTBAActive equity options trading on open
Active equity options trading on open: AAPL BAC FB BA TWTR NFLX WMT BABA
08:22 EDTTSprint traffic levels increasing, says Pacific Crest
Subscribe for More Information
07:41 EDTYHOOYahoo price target lowered to $56 from $62 at Cantor
Subscribe for More Information
August 18, 2015
11:34 EDTTSprint rises on plans to abandon two-year contracts
Sprint shares are higher this morning after the company's chief executive officer said that the carrier plans to move away from two-year contracts. WHAT'S NEW: In an interview with The Wall Street Journal, Sprint CEO Marcelo Claure said that the company will stop offering two-year contracts by the end of 2015 in favor of a "smartphone lease" model. Sprint began offering a lease option last year, The Journal noted, and Claure said the carrier is planning to move entirely to that model by the end of the year. As part of its shift, Sprint yesterday unveiled iPhone Forever, a new leasing plan that starts at $22 per month for an iPhone. WHAT'S NOTABLE: In a similar move earlier this month, Sprint rival Verizon (VZ) said it would drop phone subsidies and two-year contracts for new customers. T-Mobile (TMUS), another market rival, abandoned contracts over two years ago, leaving AT&T (T) as the only major U.S. carrier still offering to subsidize new smartphone purchases. Separately, Softbank (SFTBF), Sprint's primary stakeholder, disclosed last week that it increased its holdings in the company to approximately 80%, though the company said it does not plan for its stake in the carrier to exceed 85%. Meanwhile, a study released Tuesday by RootMetrics, an independent company that evaluates wireless networks, shows that Sprint is improving its network, having solidified third place nationally in overall performance, surpassing T-Mobile for the second consecutive six-month stretch. PRICE ACTION: Sprint is up 7c, or 1.52%, to $4.67 in morning trading.
06:03 EDTBABoeing's test flight of aerial refueling tanker to be delayed, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use